PRKAA1 and Hypercholesterolemia: A likely mechanism for Ezetimibe-induced AMPK phosphorylation was elucidated in a recent report suggesting that Ezetimibe increases the oxygen consumption rate (OCR) and reduces the amount of adenosine triphosphate (ATP) in subjects with hypercholesterolemia [39].